In 2018 Rebecca was diagnosed with a rare neuroendocrine cancer which resulted in a sudden removal of her left lung. At that time, she was Director of Business Development with a prominent laboratory equipment supplier serving the cannabis industry in North America.
From chronic fatigue or menstrual cramps to cancer-related pain and anxiety she was able to find relief from cannabis. This led to a passionate quest to understand the science and production process more deeply behind cannabis products and medicines.
Her strong background in cannabis led to her relocation from the US to the UK to join the AGI International team as Business Development Manager. She has been using her voice to spread awareness through education about the potential benefits of cannabis use for therapeutic purposes.
As a member of PLEA’s advisory board, she also attends UK Cannabis Industry Council meetings and participates in Drug Science’s Medical Cannabis Working Group. As cannabis continues to grow into a global conversation Rebecca will be at the forefront of the movement championing for education and drug policy reform.